L. Larry Wood's most recent trade in Edwards Lifesciences Corp was a trade of 8,950 Common Stock done at an average price of $75.2 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 75.23 per share. | 16 Jun 2025 | 8,950 | 206,900 (0%) | 0% | 75.2 | 673,268 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 16 Jun 2025 | 8,950 | 215,850 (0%) | 0% | 59.3 | 530,347 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 8,950 | 44,750 | - | - | Employee Stock Option (Right to Acquire) | |
| Procept BioRobotics Corp | Larry L. Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 2,771 | 2,771 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Larry L. Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 1,538 | 5,968 | - | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.68 per share. | 11 May 2025 | 988 | 206,900 (0%) | 0% | 73.7 | 72,796 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 62,000 | 62,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 11,050 | 11,050 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 11,050 | 207,888 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.92 per share. | 07 May 2025 | 819 | 196,838 (0%) | 0% | 74.9 | 61,359 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.65 per share. | 03 May 2025 | 410 | 197,657 (0%) | 0% | 75.7 | 31,017 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.65 per share. | 03 May 2025 | 396 | 198,067 (0%) | 0% | 75.6 | 29,957 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.19 per share. | 16 Feb 2025 | 333 | 198,192 (0%) | 0% | 76.2 | 25,371 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 65.91 per share. | 05 Nov 2024 | 25,000 | 198,525 (0%) | 0% | 65.9 | 1,647,863 | Common Stock |
| Procept BioRobotics Corp | Larry L. Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,526 | 2,526 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Larry L. Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 1,376 | 4,430 | - | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 985 | 223,525 (0%) | 0% | 86.7 | 85,419 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 51,700 | 51,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 8,725 | 225,205 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 8,725 | 8,725 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 695 | 224,510 (0%) | 0% | 85.1 | 59,138 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 6,675 | 0 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 6,675 | 220,021 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 3,541 | 216,480 (0%) | 0% | 85.2 | 301,870 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 395 | 213,346 (0%) | 0% | 85.1 | 33,599 | Common Stock |
| Procept BioRobotics Corp | Larry L. Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 5,284 | 5,284 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Larry L. Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 3,054 | 3,054 | - | 0 | Common Stock | |
| Edwards Lifesciences Corp | Wood L. Larry | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.04 per share. | 16 Feb 2024 | 317 | 213,476 (0%) | 0% | 86.0 | 27,275 | Common Stock |
| Edwards Lifesciences Corp | Wood L. Larry | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Dec 2023 | 8,658 | 222,451 (0%) | 0% | 45.3 | 392,006 | Common Stock |
| Edwards Lifesciences Corp | L. Larry Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 71.86 per share. | 13 Dec 2023 | 8,658 | 213,793 (0%) | 0% | 71.9 | 622,164 | Common Stock |
| Edwards Lifesciences Corp | Larry Wood L. | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 8,658 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Wood Larry L. | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2023 | 8,660 | 8,658 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | L. Larry Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Nov 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Edwards Lifesciences Corp | Larry Wood L. | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 65.64 per share. | 13 Nov 2023 | 5,402 | 213,793 (0%) | 0% | 65.6 | 354,565 | Common Stock |
| Edwards Lifesciences Corp | L. Larry Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 64.68 per share. | 13 Nov 2023 | 3,158 | 219,195 (0%) | 0% | 64.7 | 204,274 | Common Stock |
| Edwards Lifesciences Corp | L. Larry Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 66.21 per share. | 13 Nov 2023 | 100 | 222,353 (0%) | 0% | 66.2 | 6,621 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2023 | 8,660 | 17,318 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Oct 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 70.26 per share. | 13 Oct 2023 | 5,150 | 213,793 (0%) | 0% | 70.3 | 361,864 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 69.61 per share. | 13 Oct 2023 | 3,510 | 218,943 (0%) | 0% | 69.6 | 244,334 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Sep 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 73.63 per share. | 14 Sep 2023 | 8,660 | 213,793 (0%) | 0% | 73.6 | 637,615 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2023 | 8,660 | 25,978 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Aug 2023 | 6,421 | 220,214 (0%) | 0% | 45.3 | 290,722 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2023 | 6,421 | 34,638 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 79.30 per share. | 14 Aug 2023 | 6,421 | 213,793 (0%) | 0% | 79.3 | 509,185 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 8,660 | 41,059 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Jul 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 92.94 per share. | 14 Jul 2023 | 8,660 | 213,793 (0%) | 0% | 92.9 | 804,843 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 8,660 | 49,719 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Jun 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 89.87 per share. | 14 Jun 2023 | 5,810 | 213,793 (0%) | 0% | 89.9 | 522,152 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 90.71 per share. | 14 Jun 2023 | 2,850 | 219,603 (0%) | 0% | 90.7 | 258,528 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 84.23 per share. | 24 May 2023 | 6,421 | 213,793 (0%) | 0% | 84.2 | 540,841 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 6,421 | 58,379 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 24 May 2023 | 6,421 | 220,214 (0%) | 0% | 45.3 | 290,722 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 65,700 | 65,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 9,725 | 9,725 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 7,775 | 213,793 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP & Grp President TAVR & SSH | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 5,415 | 210,365 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP & Grp President TAVR & SSH | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 5,415 | 1,485 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP & Grp President TAVR & SSH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 2,583 | 207,782 (0%) | 0% | 88.7 | 229,215 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP & Grp President TAVR & SSH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 1,472 | 206,310 (0%) | 0% | 88.7 | 130,625 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP & Grp President TAVR & SSH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.10 per share. | 03 May 2023 | 396 | 204,950 (0%) | 0% | 88.1 | 34,888 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP & Grp President TAVR & SSH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.81 per share. | 03 May 2023 | 383 | 205,346 (0%) | 0% | 87.8 | 33,631 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP & Grp President TAVR & SSH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 3,235 | 205,466 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 7,236 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Dec 2022 | 7,236 | 209,467 (0%) | 0% | 36.8 | 265,923 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 76.96 per share. | 13 Dec 2022 | 6,936 | 202,231 (0%) | 0% | 77.0 | 533,772 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 77.48 per share. | 13 Dec 2022 | 300 | 209,167 (0%) | 0% | 77.5 | 23,245 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 7,242 | 7,236 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 68.50 per share. | 08 Nov 2022 | 7,242 | 202,231 (0%) | 0% | 68.5 | 496,065 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 08 Nov 2022 | 7,242 | 209,473 (0%) | 0% | 36.8 | 266,144 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 82.12 per share. | 11 Oct 2022 | 7,242 | 202,231 (0%) | 0% | 82.1 | 594,713 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2022 | 7,242 | 14,478 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 11 Oct 2022 | 7,242 | 209,473 (0%) | 0% | 36.8 | 266,144 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 06 Sep 2022 | 7,242 | 209,473 (0%) | 0% | 36.8 | 266,144 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2022 | 7,242 | 21,720 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 89.00 per share. | 06 Sep 2022 | 7,242 | 202,231 (0%) | 0% | 89 | 644,538 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 09 Aug 2022 | 7,242 | 209,473 (0%) | 0% | 36.8 | 266,144 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 7,242 | 28,962 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 104.59 per share. | 09 Aug 2022 | 5,324 | 202,231 (0%) | 0% | 104.6 | 556,857 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 105.03 per share. | 09 Aug 2022 | 1,918 | 207,555 (0%) | 0% | 105.0 | 201,447 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 95.90 per share. | 05 Jul 2022 | 7,242 | 202,231 (0%) | 0% | 95.9 | 694,486 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 7,242 | 36,204 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Jul 2022 | 7,242 | 209,473 (0%) | 0% | 36.8 | 266,144 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 01 Jun 2022 | 7,242 | 209,441 (0%) | 0% | 36.8 | 266,144 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 7,242 | 43,446 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 100.19 per share. | 01 Jun 2022 | 4,479 | 202,199 (0%) | 0% | 100.2 | 448,738 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 101.09 per share. | 01 Jun 2022 | 2,763 | 206,678 (0%) | 0% | 101.1 | 279,315 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.93 per share. | 17 May 2022 | 1,816 | 204,253 (0%) | 0% | 95.9 | 174,209 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 13,256 | 0 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 13,256 | 214,076 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.52 per share. | 07 May 2022 | 8,007 | 206,069 (0%) | 0% | 100.5 | 804,864 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 07 May 2022 | 7,242 | 213,311 (0%) | 0% | 36.8 | 266,144 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 7,242 | 50,688 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 96.38 per share. | 07 May 2022 | 4,568 | 206,069 (0%) | 0% | 96.4 | 440,251 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 95.71 per share. | 07 May 2022 | 2,674 | 210,637 (0%) | 0% | 95.7 | 255,930 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.52 per share. | 07 May 2022 | 679 | 200,820 (0%) | 0% | 100.5 | 68,253 | Common Stock |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 39,800 | 39,800 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Larry L. Wood | CVP, TAVR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 5,550 | 5,550 | - | - | Performance Rights |